- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04357704
Improved Speech Recognition Performance in Noise by Encoding Binaural Spatial Cues to the Cochlea Implant User (APPIC)
April 21, 2020 updated by: Oticon Medical
The aim of the study is to evaluate the interaural time difference (ITD) benefit in patient with bilateral cochlear implants and to assess speech performance in noisy conditions compared to normal hearing listeners.
Half of participants are bilateral cochlear implants users, while the other are normal hearing listeners.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
Listening in noisy environments is part of everyday life, it is based on binaural phenomena such as spatial localization
Bilateral cochlear implants certainly restore a part of binaurality
Study Type
Interventional
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Fluent in local language
- Normal hearing listener:
- pure tone threshold > 25dB from 125Hz to 12kHz
- Cochlear implant recipient
- bilaterally implanted 6 months at least, the second implant should be implanted 6 months at least before participant inclusion
- Digisonic SP® cochlear implants user
Exclusion Criteria:
- binaural sensitivity threshold < 1000µs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: bilateral cochlear implant recipients
|
(no ITD)
(ITD +500µs on noise)
(ITD -500µs on signal and +500 µs on noise)
(ITD + 1000 µs on noise)
(no ITD cue, with uncorrelated stimulation frame)
|
Active Comparator: normal hearing listners
|
(no ITD)
(ITD +500µs on noise)
(ITD -500µs on signal and +500 µs on noise)
(ITD + 1000 µs on noise)
(no ITD cue, with uncorrelated stimulation frame)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
speech reception threshold (SRT) in bilateral cochlear implant user with ITD cue
Time Frame: day 0
|
SRT is used as an outcome measure to quantify the acuity for speech perception in noise with Interaural Time Difference between the two ears.
Signal recognition in a background noise is assessed the following conditions S0N0, S0N500, S0N1000, S-500N500 et S0Nuncorr.
The noise level is constant at 65 dB SPL, the signal level is modified in the adaptive procedure in order to converge towards a score of 50% of correct response.
|
day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
speech reception threshold (SRT) in bilateral cochlear implant user without ITD cue and in normal hearing listeners
Time Frame: day 0
|
SRT is used as an outcome measure to quantify the acuity for speech perception in noise without Interaural Time Difference between the two ears.
|
day 0
|
ITD sensitivity in bilateral cochlear implant user
Time Frame: day 0
|
Speech signal and noise are presented at 65dB SPL.
Participant adjust the Interaural Time Difference between the speech signal and noise between -1000 and +1000µs.
Participant moves the cursor on the interface until he/she hear a difference in sound.
|
day 0
|
Preferred jitter in bilateral cochlear implant user
Time Frame: day 0
|
Speech signal and noise are presented at 65dB SPL.
Participant adjust the jitter of the train pulse timing from 0 to +1000µs to improve the Interaural Time Difference.
|
day 0
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nicolas Guevara, MD, Hospital University Nice-IUFC
- Principal Investigator: Alexis Bozorg-Grayeli, MD, Hospital University Dijon-François Mitterrand
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
April 1, 2019
Primary Completion (Anticipated)
June 1, 2019
Study Completion (Anticipated)
September 1, 2019
Study Registration Dates
First Submitted
November 27, 2018
First Submitted That Met QC Criteria
April 21, 2020
First Posted (Actual)
April 22, 2020
Study Record Updates
Last Update Posted (Actual)
April 22, 2020
Last Update Submitted That Met QC Criteria
April 21, 2020
Last Verified
November 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PIC_10
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss, Cochlear
-
Oticon MedicalTerminatedHearing Loss, Sensorineural | Hearing Loss, Bilateral | Cochlear Hearing Loss | Hearing Loss, CochlearFrance
-
Hospices Civils de LyonCompletedHearing Loss | Deafness | Cochlear Hearing Loss | Cochlear Nerve Deafness | Cochlear DiseasesFrance
-
Cambridge University Hospitals NHS Foundation TrustAdvanced Bionics AGCompletedHearing Loss, Bilateral | Cochlear Implant | Hearing Loss, Cochlear | Severe-Profound Hearing LossUnited Kingdom
-
CochlearTerminatedTinnitus, Hearing Loss, Cochlear Implant UsersNetherlands
-
University GhentUniversity Hospital, GhentRecruitingHearing Loss, Sensorineural | Cochlear Hearing Loss | Cochlear SynaptopathyBelgium
-
NYU Langone HealthWithdrawnCochlear Hearing Loss | Cochlear ImplantUnited States
-
Oticon MedicalWithdrawnCochlear Hearing Loss | Cochlear Trauma
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Oticon MedicalCompletedSensorineural Hearing Loss | Cochlear Hearing LossFrance
-
University Hospital, AntwerpCochlearRecruitingHearing Loss, Unilateral | Cochlear Implants | Hearing Loss, Sensorineural, Severe | Hearing Loss, Sensorineural, Bilateral | Hearing Loss, Sensorineural, ProfoundBelgium